Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108


Accelerated development of chronic lymphocytic leukemia in New Zealand Black mice expressing a low level of interferon regulatory factor 4.

Ma S, Shukla V, Fang L, Gould KA, Joshi SS, Lu R.

J Biol Chem. 2013 Sep 13;288(37):26430-40. doi: 10.1074/jbc.M113.475913.


A role for IRF4 in the development of CLL.

Shukla V, Ma S, Hardy RR, Joshi SS, Lu R.

Blood. 2013 Oct 17;122(16):2848-55. doi: 10.1182/blood-2013-03-492769.


Interferon regulatory factor 4 attenuates Notch signaling to suppress the development of chronic lymphocytic leukemia.

Shukla V, Shukla A, Joshi SS, Lu R.

Oncotarget. 2016 Jul 5;7(27):41081-41094. doi: 10.18632/oncotarget.9596.


The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia.

Salerno E, Yuan Y, Scaglione BJ, Marti G, Jankovic A, Mazzella F, Laurindo MF, Despres D, Baskar S, Rader C, Raveche E.

Cytometry B Clin Cytom. 2010;78 Suppl 1:S98-109. doi: 10.1002/cyto.b.20544.


Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model.

Scaglione BJ, Salerno E, Balan M, Coffman F, Landgraf P, Abbasi F, Kotenko S, Marti GE, Raveche ES.

Br J Haematol. 2007 Dec;139(5):645-57. Review.


The NZB mouse as a model for chronic lymphocytic leukemia.

Phillips JA, Mehta K, Fernandez C, Raveché ES.

Cancer Res. 1992 Jan 15;52(2):437-43.


IRF4 mutations in chronic lymphocytic leukemia.

Havelange V, Pekarsky Y, Nakamura T, Palamarchuk A, Alder H, Rassenti L, Kipps T, Croce CM.

Blood. 2011 Sep 8;118(10):2827-9. doi: 10.1182/blood-2011-04-350579.


Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice.

Raveche ES, Salerno E, Scaglione BJ, Manohar V, Abbasi F, Lin YC, Fredrickson T, Landgraf P, Ramachandra S, Huppi K, Toro JR, Zenger VE, Metcalf RA, Marti GE.

Blood. 2007 Jun 15;109(12):5079-86.


IRF4(-/-)Vh11 mice: a novel mouse model of CLL.

Zhong Y, Byrd JC.

Blood. 2013 Oct 17;122(16):2769-70. doi: 10.1182/blood-2013-08-521120. No abstract available.


Alterations in the mir-15a/16-1 Loci Impairs Its Processing and Augments B-1 Expansion in De Novo Mouse Model of Chronic Lymphocytic Leukemia (CLL).

Kasar S, Underbayev C, Hassan M, Ilev I, Degheidy H, Bauer S, Marti G, Lutz C, Raveche E, Batish M.

PLoS One. 2016 Mar 9;11(3):e0149331. doi: 10.1371/journal.pone.0149331.


H-2z homozygous New Zealand mice as a model for B-cell chronic lymphocytic leukemia: elevated bcl-2 expression in CD5 B cells at premalignant and malignant stages.

Okamoto H, Nishimura H, Shinozaki A, Zhang D, Hirose S, Shirai T.

Jpn J Cancer Res. 1993 Dec;84(12):1273-8.


Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia.

Kasar S, Underbayev C, Yuan Y, Hanlon M, Aly S, Khan H, Chang V, Batish M, Gavrilova T, Badiane F, Degheidy H, Marti G, Raveche E.

Oncogene. 2014 Jun 19;33(25):3307-15. doi: 10.1038/onc.2013.291.


An intronic polymorphism of IRF4 gene influences gene transcription in vitro and shows a risk association with childhood acute lymphoblastic leukemia in males.

Do TN, Ucisik-Akkaya E, Davis CF, Morrison BA, Dorak MT.

Biochim Biophys Acta. 2010 Feb;1802(2):292-300. doi: 10.1016/j.bbadis.2009.10.015.


Altered response to and production of TGF-beta by B cells from autoimmune NZB mice.

Douglas RS, Woo EY, Capocasale RJ, Tarshis AD, Nowell PC, Moore JS.

Cell Immunol. 1997 Aug 1;179(2):126-37.


Regulatory T cells as central regulators of both autoimmunity and B cell malignancy in New Zealand Black mice.

Scaglione BJ, Salerno E, Gala K, Pan M, Langer JA, Mostowski HS, Bauer S, Marti G, Li Y, Tsiagbe VK, Raveche ES.

J Autoimmun. 2009 Feb;32(1):14-23. doi: 10.1016/j.jaut.2008.10.001.


The correlation of telomerase and IL-10 with leukemia transformation in a mouse model of chronic lymphocytic leukemia (CLL).

Peng B, Zhang M, Sun R, Lin YC, Chong SY, Lai H, Stein D, Raveche ES.

Leuk Res. 1998 Jun;22(6):509-16.


IRF4 is a suppressor of c-Myc induced B cell leukemia.

Pathak S, Ma S, Trinh L, Eudy J, Wagner KU, Joshi SS, Lu R.

PLoS One. 2011;6(7):e22628. doi: 10.1371/journal.pone.0022628.


Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy.

Schmidt M, Hochhaus A, König-Merediz SA, Brendel C, Proba J, Hoppe GJ, Wittig B, Ehninger G, Hehlmann R, Neubauer A.

J Clin Oncol. 2000 Oct 1;18(19):3331-8.


Fine-scale mapping of the 6p25.3 chronic lymphocytic leukaemia susceptibility locus.

Crowther-Swanepoel D, Broderick P, Ma Y, Robertson L, Pittman AM, Price A, Twiss P, Vijayakrishnan J, Qureshi M, Dyer MJ, Matutes E, Dearden C, Catovsky D, Houlston RS.

Hum Mol Genet. 2010 May 1;19(9):1840-5. doi: 10.1093/hmg/ddq044.


Genetic factors predisposing to B-CLL and to autoimmune disease in spontaneous murine model.

Hirose S, Hamano Y, Shirai T.

Leukemia. 1997 Apr;11 Suppl 3:267-70.

Items per page

Supplemental Content

Support Center